Andrew N. Nathanson
- Obtained a decision by the Connecticut Supreme Court that reversed an injunction and a seven-figure judgment against our client on trade secret and unfair competition claims.
- Represented the appellant in this case concerning tax liabilities relating to escrow release contracts arising out of the settlements of class action tobacco litigation.
- Represented a Canadian insurance company in its reinsurance contract dispute with an American insurance company. The US Court of Appeals for the First Circuit affirmed the District of Massachusetts’s award of summary judgment to our client.

Mintz litigators achieved a complete victory on behalf of our client Keryx Biopharmaceuticals in a putative securities class action case seeking over $100 million in damages.

Mintz secured two MA federal court wins and one at the First Circuit for Vertex Pharmaceuticals, Inc. and several senior executives in a securities case about clinical trial result disclosures. The decision clarified the First Circuit standard for pleading scienter in securities fraud cases.

Mintz helped GE respond to EPA allegations about its earlier material sales and demand that GE implement a multimillion-dollar cleanup of a federal Superfund Site. Mintz represented GE at trial and on appeal to the First Circuit and caused a change in the remedy GE was required to implement.

Mintz represents GE in a dispute concerning the EPA’s costly proposed remedy for the Housatonic Rest of River, which offers no additional environmental or human health benefit. The EPA Environmental Appeals Board recently took the usual step of remanding EPA’s proposal for further consideration.

Mintz represented a client alleged to be responsible for the contamination of a public water supply. Mintz attorneys led an investigation of the state’s theory, including working with a leading hydrogeologist and locating the client's former employees. The state ultimately abandoned its claims.